Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.1.5 (
neuropathy target esterase
)
1,070
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Serum stimulates both Ca2+ mobilization and colony growth of many
small cell lung cancer
(
SCLC
) cell lines, but the factors involved remain unknown. We demonstrate that 1-oleoyl-lysophosphatidic acid (LPA), like serum, induced a dose-dependent increase in intracellular Ca2+ in the H-510, H-345, and H-69
SCLC
cell lines with half maximal concentrations of 18 nM, 22 nM, and 20 nM, respectively. Two lines of evidence revealed that LPA was the major factor in serum responsible for mobilizing Ca2+ in these
SCLC
cell lines: (a) both LPA and serum exhibited cross desensitization in the Ca2+ mobilization assay; and (b)
phospholipase B
pretreatment of either LPA or serum prevented the ability of these agents to stimulate Ca2+ mobilization. In marked contrast, LPA at concentrations between 2 nM and 20 microM, unlike serum, failed to stimulate colony formation. Furthermore,
phospholipase B
treatment of serum did not inhibit serum-induced colony formation. We therefore searched for growth factors which could induce colony growth through a Ca(2+)-independent pathway. We found that both human recombinant hepatocyte growth factor and stem cell growth factor increased colony growth, but failed to stimulate an increase in intracellular Ca2+ in the H-510, H-345, and H-69
SCLC
cell lines. Our results indicate that LPA-depleted serum, hepatocyte growth factor, and stem cell growth factor stimulate colony formation in
SCLC
cells through a Ca(2+)-independent pathway.
...
PMID:Lysophosphatidic acid-depleted serum, hepatocyte growth factor and stem cell growth factor stimulate colony growth of small cell lung cancer cells through a calcium-independent pathway. 752 56